同仁堂
Search documents
同仁堂回应磷虾油涉嫌造假;复星医药14.12亿元收购绿谷医药 | 健讯Daily
2 1 Shi Ji Jing Ji Bao Dao· 2025-12-16 00:04
Policy Developments - The National Medical Insurance Administration has issued a three-year action plan to enhance the efficiency of medical insurance fund settlement, aiming to complete annual settlements by March 31 each year starting in 2028, with settlement funds accounting for about 3% of the annual medical insurance fund allocation [2] Medical Device Approvals - Jiukang Bio has received a medical device registration certificate for its fructosamine testing kit, which is expected to enhance its product line in the in vitro diagnostic sector [5] - Yihuilong has obtained registration for its anti-phosphatidylserine/prothrombin IgM and IgG antibody testing kits, which will expand its automated chemiluminescence product line [6] - Kangzheng Pharmaceutical's oral JAK1 inhibitor, Povorcitinib, has been included in the "Breakthrough Therapy" list for treating non-segmental vitiligo in adults [7] Capital Market Activities - Fosun Pharma plans to invest a total of 1.412 billion yuan in Green Valley Pharmaceutical, acquiring a 53% stake through its subsidiary [9] - Paig Bio-Medical has announced a further extension of the lock-up period for cornerstone investors until April 30, 2026, and is raising approximately 296 million HKD for various strategic initiatives [10][11] Industry Developments - Nanjing has established a medical health merger and acquisition equity investment fund with a total investment of 800 million yuan, focusing on equity investment and asset management [13] - Zhenghai Bio has signed a 12 million yuan technical development contract with the Chinese Academy of Agricultural Sciences for the research and development of recombinant type III collagen products [14] - MicroPort Robotics has established a new medical technology company with a registered capital of 15 million yuan, focusing on the development and manufacturing of service robots [15] Public Opinion Alerts - Tongrentang has responded to allegations of false labeling regarding its Antarctic krill oil product, initiating legal action against the involved parties to protect consumer rights [17]
同仁堂回应磷虾油涉嫌造假;复星医药14.12亿元收购绿谷医药
2 1 Shi Ji Jing Ji Bao Dao· 2025-12-15 23:52
Policy Developments - The National Healthcare Security Administration (NHSA) has issued a three-year action plan to enhance the efficiency of medical insurance fund settlement, aiming to complete annual settlements by March 31 each year starting in 2028, with settlement funds accounting for about 3% of the annual medical insurance fund allocation [2] - This plan represents a systemic reform of the medical insurance system, addressing issues such as slow reimbursements for insured individuals and funding for medical institutions in the short term, while promoting scientific and refined management of medical insurance funds in the medium term [2] Medical Device Registration - The Deputy Director of the National Medical Products Administration, Lei Ping, attended a regional meeting on medical device registration management and conducted field research in Guangdong and Yunnan, emphasizing the need to align with the health demands of the people and plan for high-quality development in the medical device sector [3] Company Announcements - Jiukang Bio has received a medical device registration certificate for its fructosamine testing kit, which is expected to enhance its competitiveness in the in vitro diagnostic market, although future sales remain uncertain [5] - Yihuilong has obtained registration for its anti-phosphatidylserine/prothrombin IgM and IgG antibody testing kits, which will expand its product line in the autoimmune disease testing sector, with sales dependent on market conditions [6] - Kangzheng Pharmaceutical announced that its oral JAK1 inhibitor, Povorcitinib, has been included in the "Breakthrough Therapy" list for treating non-segmental vitiligo in adults [7] Capital Market Activities - Fosun Pharma plans to invest a total of 1.412 billion yuan in Green Valley Pharmaceutical, acquiring a 53% stake through its subsidiary [9] - Paig Bio Pharma-B has announced a further extension of the lock-up period for cornerstone investors until April 30, 2026, and is raising approximately 296 million HKD for various strategic initiatives [10] Industry Developments - A new medical health equity investment fund has been established in Nanjing with a total investment of 800 million yuan, focusing on private equity investments and asset management [12] - Zhenghai Bio has signed a 12 million yuan technology development contract with the Chinese Academy of Agricultural Sciences for the research and development of recombinant type III collagen products [13] - Beijing Weisi Weixiang Medical Technology Co., Ltd. has been established with a registered capital of 15 million yuan, focusing on the development and manufacturing of service robots [14] - Tongrentang Health has taken action against a product falsely labeled as produced by its subsidiary, initiating legal proceedings to protect consumer rights [15]
早报 | 杭州小米交付中心发生车祸,最新回应;L3级自动驾驶来了;中美卫星惊险“擦肩”;蜜雪冰城回应7.9元早餐套餐被嫌贵
虎嗅APP· 2025-12-15 23:50
Group 1: Automotive Industry - A traffic accident occurred at Xiaomi's delivery center in Hangzhou, involving a new car owner and a sales staff member, with the vehicle in human driving mode at the time of the incident [2] - China's Ministry of Industry and Information Technology announced the first batch of L3 conditional autonomous driving vehicle approvals, with Changan Automobile and BAIC Jihe being the first companies to receive permits for trial operations [8] - Tesla confirmed ongoing tests of fully autonomous Robotaxi vehicles in Austin, Texas, with the stock price rising by 3.5% to $475.11 following the announcement [9][10] Group 2: Technology and AI - NVIDIA launched the Nemotron 3 open model series, featuring three models with varying parameter sizes, aimed at enhancing AI workflows [7] - OpenAI hired Albert Lee from Google to lead corporate development, indicating a focus on strategic investments and acquisitions to compete with rivals [11] - Google CEO Sundar Pichai warned of irrational factors in the AI market, suggesting that a bubble burst could affect all companies, while emphasizing the long-term value of AI technology [24][25][26] Group 3: Consumer Goods - McDonald's China announced a price increase for various menu items, with most items seeing a rise of 0.5 to 1 yuan, effective December 15 [15] - Mijia Ice City faced criticism for a 7.9 yuan breakfast combo, which some consumers deemed expensive compared to competitors [16] Group 4: Corporate Developments - iRobot filed for bankruptcy protection, planning to be acquired by its Chinese supplier, with a significant drop in stock price following the announcement [12]
【钛晨报】持续讲好“股市叙事”!证监会最新发声;中国首批L3级自动驾驶车型产品获得准入许可;沐曦股份上市在即,壁仞科技港股IPO获备案
Sou Hu Cai Jing· 2025-12-15 23:40
【钛媒体综合】近日,中国证监会党委书记、主席吴清主持召开党委(扩大)会议,传达学习中央经济工作会议精神,结合全国金融系统工作会议要求,研 究部署证监会系统贯彻落实举措。 会议强调,这次中央经济工作会议对资本市场工作作出重要部署,充分体现了党中央对资本市场的高度重视和殷切期望。证监会系统要深入学习贯彻习近平 总书记重要讲话精神,认真落实中央经济工作会议部署,按照全国金融系统工作会议安排,坚持稳中求进、提质增效,紧扣防风险、强监管、促高质量发展 主线,持续深化资本市场投融资综合改革,更好助力稳就业、稳企业、稳市场、稳预期,为经济高质量发展和"十五五"良好开局积极贡献力量。 一是坚持战略引领,认真做好"十五五"规划编制和实施。积极配合编制国家"十五五"规划纲要,科学制定资本市场"十五五"规划体系,系统谋划未来五年资 本市场发展主要目标、任务和重要举措,以钉钉子精神抓好落实。 二是坚持固本强基,持续增强市场内在稳定性。积极培育高质量上市公司群体,开展新一轮公司治理专项行动,引导优质公司持续加大分红回购力度。全面 推动落实中长期资金长周期考核机制,大力发展权益类公募基金,推动指数化投资高质量发展。加强跨市场跨行业跨境风 ...
仅200米 中美卫星惊险“擦肩”;L3级自动驾驶来了 两款车获批丨每经早参
Mei Ri Jing Ji Xin Wen· 2025-12-15 22:49
Market Overview - US stock markets experienced a collective decline, with the Dow Jones down 0.09%, Nasdaq down 0.59%, and S&P 500 down 0.16% [5] - International oil prices fell, with WTI crude oil down 1.50% at $56.58 per barrel and Brent crude down 1.31% at $60.32 per barrel [6] - International gold prices increased slightly, with spot gold up 0.1% at $4304.51 per ounce [7] - European stock indices closed higher, with Germany's DAX up 0.07%, France's CAC40 up 0.7%, and the UK's FTSE 100 up 1.06% [8] Economic Policies and Developments - The Ministry of Commerce and five other departments released an action plan to promote high-quality development in the service outsourcing sector, aiming to cultivate competitive enterprises and enhance digital, intelligent, and green development by 2030 [9] - The China Securities Regulatory Commission (CSRC) is accelerating the implementation of the "1+6" reform measures for the Sci-Tech Innovation Board, focusing on enhancing market inclusivity and attracting investment [10] Real Estate Market - In November, the number of cities with rising new home prices increased to 8, with Shanghai seeing a year-on-year increase of 5.1%, followed by Hangzhou at 3% and Hefei at 1.3% [11] Energy Consumption - By 2025, China's total electricity consumption is expected to exceed 10 trillion kilowatt-hours for the first time, marking a significant milestone in the country's energy development [12] Automotive Industry - Changan Automobile and BAIC Blue Valley have received approval for L3-level conditional autonomous driving vehicles, indicating advancements in China's smart connected vehicle technology [17][18] Financial Sector - China CITIC Bank clarified that it has never collaborated with "KOO Wallet," addressing concerns over potential financial fraud [19][20] - Kweichow Moutai denied rumors regarding its product supply and pricing policies, emphasizing the authenticity of its communications [21] Corporate Actions - 1919 Group's founder acquired a 73.63% stake in Yiyuan Wine Industry, expanding the presence of Chengdu-based companies in the Hong Kong stock market [22] - Beijing Tongrentang announced legal action against a company for falsely labeling a product, reinforcing its commitment to brand integrity [24] - Wall Street's McDonald's has raised prices by 0.5 to 1 yuan on various menu items, reflecting cost pressures in the food service industry [27] Technology and Innovation - Tesla is testing a driverless ride-hailing service in Austin, Texas, without a safety driver, showcasing advancements in autonomous driving technology [28]
特朗普:将起诉BBC;欧洲提议组建“多国部队”支持乌克兰;仅200米,中美卫星惊险“擦肩”;L3级自动驾驶来了,两款车获批丨每经早参
Mei Ri Jing Ji Xin Wen· 2025-12-15 22:11
每经编辑|张喜威 王晓波 V 第二届中国天然气技术与装备交流大和 月16日至18日在苏州召开 2 恒生港股通软件及半导体指数将更名, 芯国际、华虹半导体等四股,12月16日 3 欧元区12月制造业PMI初值将公布 4 美国12月标普全球制造业PMI初值将红 5 美国11月失业率、非农就业人口数据: 1 隔夜市场 美股三大指数集体收跌,道指跌0.09%,纳指跌0.59%,标普500指数跌0.16%,博通跌超5%,苹果、亚马逊涨超1%,特斯拉涨超3%;加密矿企、货币储备 概念跌幅居前,Hut8跌超14%,Circle跌超9%,Coinbase跌超6%;汽车制造、贵金属、旅游、减肥药板块走高,丰田汽车、礼来涨超3%,安进、辉瑞、罗氏 涨超2%。美国扫地机器人鼻祖iRobot申请破产,股价大跌超过70%,一度触发熔断机制,最终收跌72.69%,总市值仅剩下0.4亿美元(约合人民币2.8亿 元)。纳斯达克中国金龙指数收跌2.17%,中概股普跌,百度跌近5%,金山云跌超4%,知乎、阿里巴巴、小鹏汽车跌超3%,理想汽车、好未来跌超2%, 名创优品涨超2%。 纳斯达克称将于周一向美国证券交易委员会提交文件,申请推出近乎全天候 ...
产品涉嫌虚假标注 同仁堂将起诉子公司
Zhong Guo Jing Ying Bao· 2025-12-15 15:59
相关文章称,一款标称"北京同仁堂99%高纯南极磷虾油"的产品,在网页上写着"高含量""智利进口原料""高度提纯""1粒≈100只磷虾",其磷脂标 识值为43%,看似是品质出众的优质产品,但检测结果显示该款产品磷脂含量为0。 专家表示,南极磷虾油产品应该是以南极磷虾为原料提取的虾油,必定含有磷脂成分。针对相关企业涉嫌造假行为,为了保护消费者合法权 益,上海市消保委将于近日约谈该产品的生产企业安徽哈博药业有限公司和经销商同仁堂四川健康药业,要求其对产品的真实情况作出解释。 2025年12月15日,北京同仁堂发布声明表示,已启动司法程序,起诉控股51%的子公司北京同仁堂(四川)健康药业有限公司(以下简称"同仁 堂四川健康药业")。 北京同仁堂声明称:"近日,有媒体报道一款标注'安徽哈博药业有限公司生产、同仁堂四川健康药业经销'的'99%高纯南极磷虾油'产品,相关成 分涉嫌虚假标注。针对上述情况,我公司立即责令同仁堂四川健康药业停止经销该产品,并对涉事产品开展全流程核查与追溯。" 同仁堂四川健康药业注册成立于2000年6月,由北京同仁堂控股,其余两名股东为个人。 今年12月11日,"上海消保委"微信公众号发文称,知名 ...
北京同仁堂“甩锅”孙公司?相关磷虾油产品尚未下架
Di Yi Cai Jing Zi Xun· 2025-12-15 15:33
12月15日,北京同仁堂健康药业股份有限公司发布声明称,针对上述情况,公司立即责令四川健康药业 停止经销该产品,并对涉事产品开展全流程核查与追溯。北京同仁堂健康药业还称,这款产品未经授权 擅自突出使用"北京同仁堂"字样,涉嫌违法,公司已启动司法程序,对涉事企业进行起诉。 2025.12.15 本文字数:1026,阅读时长大约2分钟 作者 |第一财经 钱童心 近日,上海市消保委称一款标注"安徽哈博药业有限公司生产、北京同仁堂(四川)健康药业有限公司 经销"的"99%高纯南极磷虾油"产品,相关成分涉嫌虚假标注。为此,上海市消保委已约谈生产厂家及 产品经销商。 此外,对于虚标质量成分的产品,游云庭表示,消费者可以向产品生产者及经销商要求索赔,依据有两 个:一是按照《消费者保护法》,如果是涉嫌欺诈消费者,可以要求退一赔三;二是如果食药监部门认 为产品涉及食品安全问题,根据《食品安全法》,生产商和经销商可以被要求退一赔十,并且如果赔偿 金额不足1000元的,至少要赔偿1000元。 微信编辑| 小羊 第一财经持续追踪财经热点。若您掌握公司动态、行业趋势、金融事件等有价值的线索,欢迎提供。专 用邮箱:bianjibu@yi ...
北京同仁堂“甩锅”孙公司?相关磷虾油产品尚未下架
第一财经· 2025-12-15 15:23
2025.12. 15 本文字数:1026,阅读时长大约2分钟 作者 | 第一财经 钱童心 近日,上海市消保委称一款标注"安徽哈博药业有限公司生产、北京同仁堂(四川)健康药业有限公 司经销"的"99%高纯南极磷虾油"产品,相关成分涉嫌虚假标注。为此,上海市消保委已约谈生产厂 家及产品经销商。 此外,对于虚标质量成分的产品,游云庭表示,消费者可以向产品生产者及经销商要求索赔,依据有 两个:一是按照《消费者保护法》,如果是涉嫌欺诈消费者,可以要求退一赔三;二是如果食药监部 门认为产品涉及食品安全问题,根据《食品安全法》,生产商和经销商可以被要求退一赔十,并且如 果赔偿金额不足1000元的,至少要赔偿1000元。 微信编辑 | 小羊 第 一 财 经 持 续 追 踪 财 经 热 点 。 若 您 掌 握 公 司 动 态 、 行 业 趋 势 、 金 融 事 件 等 有 价 值 的 线 索 , 欢 迎 提 供 。 专 用 邮 箱 : bianjibu@yicai.com (注:我们会对线索进行核实。您的隐私将严格保密。) 12月15日,北京同仁堂健康药业股份有限公司发布声明称,针对上述情况,公司立即责令四川健康 药业停止经 ...
同仁堂声明:已起诉
21世纪经济报道· 2025-12-15 13:38
12月15日,北京同仁堂健康药业股份有限公司发布声明称,近日,有媒体报道一款标注"安徽 哈博药业有限公司生产、北京同仁堂(四川)健康药业有限公司(以下简称'四川健康药业') 经销"的"99%高纯南极磷虾油"产品,相关成分涉嫌虚假标注。 针对上述情况,我公司立即责 令四川健康药业停止经销该产品,并对涉事产品开展全流程核查与追溯。 这款产品未经授权擅自突出使用"北京同仁堂"字样,涉嫌违法,我们已启动司法程序 ,对涉 事企业进行起诉,以求维护广大消费者和企业的合法权益。 来源丨红星新闻、公开资料 编辑丨江佩佩 见习编辑张嘉钰 视频丨柳润瑛 见习编辑陈泽锴 A股3800亿矿业巨头大涨,狂掷70亿布局南美金矿,江西铜业、紫金矿业也集体出手 摩尔线程两天市值蒸发近1000亿 美股盘前跌逾80%,扫地机器人鼻祖要破产了 SFC 21君荐读 这款北京同仁堂99%高纯南极磷虾油在多家店铺有售,单瓶售价在35元到100元不等。此外, 在电商平台上,还有着大量标识为"北京同仁堂(四川)健康药业有限公司出品"的产品,比如 北京同仁堂辅酶Q10软胶囊、北京同仁堂叶酸片等。 近日,上海市消保委微信公众号发布了15款不同品牌的南极磷虾油产 ...